AbbVie, along with Neurocrine Biosciences, announced that the Phase 3 ELARIS UF-II study (M12-817) of elagolix met its primary endpoint.
Kiadis Pharma has raised €23.4m of funding in a private placement of 2.6 million new shares, for developing a T-cell immunotherapy product to reduce Graft versus Host Disease (GVHD) in hematopoietic stem cell transplantations (HSCT).
Merck’s anti-PD-1 therapy Keytruda (pembrolizumab) has been granted priority review designation by the US Food and Drug Administration (FDA) for the treatment of advanced cervical cancer.
The US Food and Drug Administration (FDA) has upheld the earlier decision of turning down Hikma and Vectura’s generic version of GlaxoSmithKline’s (GSK) Advair Diskus (fluticasone propionate and salmeterol inhalation powder).
Sarepta Therapeutics has is planning to submit a new drug application (NDA) for accelerated approval of its duchenne muscular dystrophy (DMD) drug Golodirsen (SRP-4053).
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced results of a new analysis showing that Invokana (canagliflozin) significantly reduced the risk of cardiovascular (CV) death or hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) at high CV risk.
Biogen has agreed to buy Pfizer’s investigational schizophrenia drug, PF-04958242, in a deal worth about $590m.
LabCorp’s Covance Drug Development business has established a global immunology and immunotoxicology (I&I) unit to focus on the development of biologic drugs.
Prevail Therapeutics has secured $75m series A financing to advance the development of gene therapies for patients with Parkinson’s and other neurodegenerative diseases.
Praluent (alirocumab), an anti-cholesterol drug being developed by Regeneron Pharmaceuticals and Sanofi, has succeeded in the Odyssey Outcomes trial by decreasing the risk of death and heart attack in high-risk patients.
News from Twitter
Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1
All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…
#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO
Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…
Thème du congrès SOFCOT 2018 : "La Décision Médicale" pic.twitter.com/hJT5…
Exactly 3 weeks left to submit your abstract for #EUROSPINE2018 - #deadline 1 March 2018 #research #spine #SpineResearch #spineSurgery #SpinalDisorder #ScientificPaper #BasicScience #ClinicalResearch #PublishResearch @EurSpineJournal buff.ly/2ExMQ7e pic.twitter.com/Fx2Q…
Throughout the week, we are in #Bruges alongside Prof. Jan Casselman for an #Erasmus course program on #ENT imaging, held at the Oud Sint-Jan congress centre. The training of around 170 radiologists is based on images from our post-processing solution Olea Sphere®V3.0. #MRI pic.twitter.com/KSUU…
#ArtificialIntelligence is currently in the center of all discussions, medical #imaging including. What will be impacted, notably in #MSK imaging? Listen to the answer of Pr Cotten from Lille’s CHRU : youtu.be/93nLXGX4hEk
Did you know our IRIS technology may reduce ureteral injury rates by up to an estimated 49%? Protect your patient & reduce risk in the OR! pic.twitter.com/koeJ…
Wishing Medtronic co-founder Earl Bakken a very happy 94th birthday. Best wishes to you, Earl! pic.twitter.com/zdDa…
European investment group LSP closes $330m healthcare fund captis.com/?p=36537
CHF Solutions closes $18m Series F round captis.com/?p=36109
BD tacks another extension onto Bard tender offer captis.com/?p=36138
Boston Scientific takes a $3B hit on latest Lotus valve delay captis.com/?p=36199
Zebra Medical Vision to host AI1 image analytics on Google Cloud captis.com/?p=35413
Johnson & Johnson break ground on Chinese factory lnkd.in/gA9hTsu
Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News